Category Archives: Respiratory

NICE Bites – Asthma

The North West Medicines Information Service publish monthly “NICE Bites” bulletins summarising key points from NICE Clinical Guidelines and Technology Appraisals in the Implementation Section of the Specialist Pharmacy Service website – and on the East Lancashire Medicines Management site. The most recent bulletin distills 39 pages of recommendations from NICE NG 80 Asthma: diagnosis, monitoring and chronic asthma Continue Reading »

NICE asthma guidance

There are important differences between new NICE recommendations on asthma treatment and current “standard practice” in the UK. For example, NICE NG 80 recommends an early 4-8 week trial of montelukast plus low dose ICS if newly diagnosed asthma is not controlled by a low dose ICS inhaler alone. An ICS (low dose)/LABA combination is only recommended if Continue Reading »

RightBreathe website

The RightBreathe website and app has been developed by Lambeth GP, Dr Azhar Saleem, in conjunction with (amongst others) UK Medicines Information. Both the website and app have now been launched, and with details on every licensed inhaler in the UK for asthma and COPD, including links to videos and prescribing information, they provide a free-to-use, comprehensive, ‘one-stop’ Continue Reading »

Cochrane review of long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)

In a Cochrane review of 11 studies, which included 9839 participants with stable chronic COPD, LAMA+LABA treatment had fewer exacerbations, a larger improvement of FEV1, a lower risk of pneumonia, and more frequent improvement in quality of life as measured by an increase over 4 units or more of the St. George’s Respiratory Questionnaire (SGRQ) compared with LABA+ICS Continue Reading »